Applied Water Science

Sayadi, M.H. R.K. Trivedy, R.K. Pathak, Pollution of pharmaceuticals in environment, J. Ind. Pollut. Control. (2010).

Schulman, L.J., Sargent, E.V., Naumann, B.D., Faria, E..C, Dolan,. DG., John, P,. Wargo, J.P., A human health risk assessment of pharmaceuticals in the aquatic environment. Hum. Ecol. Risk Assess. 8(4), 657–680, 2002. doi:10.1080/20028091057141

Schwab, B.W. E.P. Hayes, J.M. Fiori, F.J. Mastrocco, N.M. Roden, D. Cragin, R.D. Meyerhoff, V.J. D’Aco, P.D. Anderson, Human pharmaceuticals in US surface waters: A human health risk assessment, Regul. Toxicol. Pharmacol. 42 (2005) 296–312. https://doi.org/10.1016/j.yrtph.2005.05.005.

Schwarzenbach, R.P., Escher, B.I., Fenner, K., Hofstetter, T.B., Johnson, C.A., Von Gunten, U., Wehrli, B., 2006. The challenge of micropollutants in aquatic systems. Science 313(5790), 1072–1077.

Sermejian, L., Shanableh, A., Semreen, M.H., Samarai, M., Human health risk assessment of pharmaceuticals in treated wastewater reused for non-potable applications in Sharjah, United Arab Emirates. Environ. Int. 121, 325–331, 2018. doi:10.1016/j.envint.2018.08.048

Sharma, B.M., Bečanová, J., Scheringer, M., Sharma, A., Bharat, G.K., Whitehead, P.G., Klánová, J. and Nizzetto, L., 2019. Health and ecological risk assessment of emerging contaminants (pharmaceuticals, personal care products, and artificial sweeteners) in surface and groundwater (drinking water) in the Ganges River Basin, India. Science of the Total Environment, 646, pp.1459–1467.

Sharma V.K., Yu X., McDonald T.J., Jinadatha C., Dionysiou D.D., Feng M. (2019) Elimination of antibiotic resistance genes and control of horizontal transfer risk by UV-based treatment of drinking water: A mini review. Front. Environ. Sci. Eng. 13(3): 37.

Shore, R.F., Taggart, M.A., Smits, J., Mateo, J., Richards, N.L., Frydays, S., Detection and drivers of exposure and effects of pharmaceuticals in higher vertebrates. Phil. Trans. R. Soc. B. 309, 20130570, 2014. doi:10.1098/rstb.2013.0570

Snyder, S.A. Occurrence, treatment, and toxicological relevance of EDCs and pharmaceuticals in water, in: Ozone Sci. Eng., 2008. https://doi.org/10.1080/01919510701799278.

Sorell, T.L., Approaches to the development of human health toxicity values for active pharmaceutical ingredients in the environment. Am. Assoc. Pharm. Scientists J. 18(1), 92-101, 2015. doi:10.1208/s12248-015-9818-5

Sorensen, J.P.R., Lapworth, D.J., Nkhuwa, D.C.W., Stuart, M.E., Gooddy, D.C., Bell, R.A., Chirwa, M., Kabika, J., Liemisa, M., Chibesa, M., Pedley, S., 2015. Emerging contaminants in urban groundwater sources in Africa. Water Res. https://doi.org/10.1016/j.watres.2014.08.002.

Szymonik, A., Lach, J., Malinska, K., Fate and removal of pharmaceuticals and illegal drugs present in drinking water and wastewater. Ecol. Chem. Eng. S. 24(1), 65–85, 2017. doi:10.1515/eces-2017-0006

Tarfiei, A. H. Services, H. Eslami, A.A. Ebrahimi, H. Services, of Environmental Health and Sustainable Development Pharmaceutical Pollution in the Environment and Health Hazards, (2018) 2–6.

Tian F., Ma S., Xu B., Hu X., Xing H., Liu J., Wang J., Li Y., Wang B., Jiang X. (2019) Photochemical degradation of iodate by UV/H2O2 process: Kinetics, parameters and enhanced formation of iodo-trihalomethanes during chloramination. Chemosphere 221: 292–300.

Togola. A and Budzinski. H (2007). Analytical development for analysis of pharmaceuticals in water samples by SPE and GC-MS. Anal. Bioanal. Chem. 388:627–635.

Tomasi, S., Roberts, K.J., Stull, J., Spiller, H.A., Mckenzie, L.., Pediatric exposures to veterinary pharmaceuticals. Pediatr. 139(3), e20161496, 2017. doi:10.1542/peds.2016-1496

Touraud, E., Roig, B., Sumpter, J.P., Coetsier, C., Drug residues and endocrine disruptors in drinking water: Risk for humans? Int. J. Hyg. Environ. Health 214, 437–441, 20 11. doi:10.1016/j.ijheh.2011.06.003

United States Environmental Protection Agency., Risk Assessment Guidance for Superfund Vol. 1. Human health evaluation manual (Part A). Office of Emergency and Remedial Response; Dec 1989. Report EPA/540/1-89/002, 20450, USEPA, Washington DC, (1989). https://www.epa.gov/sites/production/files/2015-09/documents/rags_a.pdf. [Accessed December 21 2019].

Vazquez-Roig. P, Andreu. V, Onghena. M, Blasco. C and Picό. Y (2011). Assessment of the occurrence and distribution of pharmaceuticals in a mediteranean wetland (L’Albufera, Valencia, Spain) LC-MS/MS. Anal. Bioanal. Chem. 400:1287–1301.

Verlicchi, P., Aukidy, M.A.l., Zambello, E., Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after secondary treatment - A review. Sci. Tot. Environ. 429, 123–155, 2012. doi:10.1016/j.scitotenv.2012.04.028

Wang H., Hu H., Wang H., Zeng R.J. (2018) Impact of dosing order of the coagulant and flocculant on sludge dewatering performance during the conditioning process. Science of the Total Environment 643: 1065–1073.

Wang, S and Wang. H (2015). Adsorption behaviour of antibiotic in soil environment: A critical review. Front. Environ. Sci. Eng. 9(4): 565–574.

Wang, Z., Han, S., Cai, M., Du, P., Zhang, Z. and Li, X., 2020. Environmental behaviour of methamphetamine and ketamine in aquatic ecosystem: Degradation, bioaccumulation, distribution, and associated shift in toxicity and bacterial community. Water Research, 174, p.115585.

Wang Z., Srivastava V., Ambat I., Safaei Z., Sillanpää M. (2019) Degradation of Ibuprofen by UV-LED/catalytic advanced oxidation process. Journal of Water Process Engineering 31: 100808.

Webb, S., Ternes, T., Gibert, M., Olejniczak, K., Indirect human exposure to pharmaceuticals via drinking water. Toxicol. Lett. 142, 157–167, 2003. doi:10.1016/S0378-427(03)00071-7 [Accessed 21 December 2019].

Wilkinson, J.L., Hooda, P.S., Barker, J., Bartron, S., Swinden, J., Ecotoxic pharmaceuticals, personal care products, and other emerging contaminants: A review of environmental, receptor-mediated, developmental, and epigenetic toxicity with discussion of proposed toxicity to humans. Crit. Rev. Environ. Sci. Technol. 46(4), 336–381, 2015. doi:10.1080/10643389.2015.1096876

World Health Organisation., Pharmaceuticals in drinking-water. WHO, Geneva, 2012. https://www.who.int/water_sanitation_health/publications/2012/pharmaceuticals/en/

Williams, E.S. B.W. Brooks, Human Health Risk Assessment for Pharmaceuticals in the Environment: Existing Practice, Uncertainty, and Future Directions, in: 2012. https://doi.org/10.1007/978-1-4614-3473-3_8.

Williams. M, Ong. P. L, Williams. D. B and Kookana. R. S (2009). Pharmaceuticals and personal care products in the environment: Estimating the sorption of pharmaceuticals based on their distribution. Environmental toxicological and chemistry 28(12): 2572–2579.

Wu Y., Zhu S., Zhang W., Bu L., Zhou S. (2019) Comparison of diatrizoate degradation by UV/chlorine and UV/chloramine processes: Kinetic mechanisms and iodinated disinfection byproducts formation. Chemical Engineering Journal 375: 121972.

Yahya N., Aziza F., Jamaludin N.A., Mutali M.A., Ismail A.F., Salleh W.N.W., Jaafar J., Yusof N., Ludin N.A. (2018) A review of integrated photocatalyst adsorbents for wastewater treatment. Journal of Environmental Chemical Engineering 6: 7411–7425.

Yang, C., Barlow, S.M., Muldoon, J.K.L., Vitcheva, V., Boobis, A.R., Felter, S. P., Arvidson, K.B., Keller, D., et al., (2017). Thresholds of toxicological concern for cosmetics-related substances: New database, thresholds, and enrichment of chemical space. Food Chem. Toxicol. 109, 170-193, 2017. doi:10.1016/j. fct.2017.08.043

Zhang Y., Chu W., Yao D., Yin D. (2017) Control of aliphatic halogenated DBP precursors with multiple drinking water treatment processes: Formation potential and integrated toxicity. Journal of Environmental Sciences 58: 322–330.